Published in Eur J Gastroenterol Hepatol on February 01, 2001
Risk of non-melanoma skin cancer in autoimmune hepatitis. Dig Dis Sci (2010) 0.76
The Role of Vitamin D in Inflammatory Bowel Disease. Healthcare (Basel) (2015) 0.75
Safety of complementary medicines should be monitored. BMJ (1995) 2.27
Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. Gastroenterology (1996) 2.13
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut (1984) 2.11
Recurrent gastrointestinal bleeding of obscure origin: report of 17 cases and a guide to logical management. Br J Surg (1983) 2.09
The urea breath test for Helicobacter pylori. Gut (1994) 2.07
Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98
Use of ethanol-induced tumor necrosis to palliate dysphagia in patients with esophagogastric cancer. Gastrointest Endosc (1990) 1.91
Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.82
Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI. Am J Physiol Gastrointest Liver Physiol (2001) 1.50
Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut (2002) 1.47
The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. J Antimicrob Chemother (1997) 1.41
Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia. Aliment Pharmacol Ther (1999) 1.40
The endoscopically abnormal duodenum in patients with dyspepsia: biopsy findings in 60 cases. Histopathology (1983) 1.34
Decreased fluid tolerance, accelerated transit, and abnormal motility of the human colon induced by oleic acid. Gastroenterology (1986) 1.26
The effect of omeprazole on gastric juice viscosity, pH and bacterial counts. Aliment Pharmacol Ther (1996) 1.24
Jejunal water and electrolyte absorption from two proprietary enteral feeds in man: importance of sodium content. Gut (1987) 1.21
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther (1999) 1.13
Pathogenesis of colonic diverticula. Br J Surg (2002) 1.10
The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther (1999) 1.08
Non-invasive quantification of small bowel water content by MRI: a validation study. Phys Med Biol (2007) 1.07
Gastric response to increased meal viscosity assessed by echo-planar magnetic resonance imaging in humans. J Nutr (2000) 1.06
Emptying of the terminal ileum in intact humans. Influence of meal residue and ileal motility. Gastroenterology (1987) 1.06
Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil (2009) 1.06
Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis (2001) 1.05
Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.04
Dissecting intramural haematoma of the oesophagus. QJM (1998) 1.04
Antral motility measurements by magnetic resonance imaging. Neurogastroenterol Motil (2001) 1.03
Visceral hypersensitivity in symptomatic diverticular disease and the role of neuropeptides and low grade inflammation. Neurogastroenterol Motil (2012) 1.01
Healing of duodenal ulcer after eradication of Helicobacter heilmannii. Lancet (1997) 0.98
Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea-predominant irritable bowel syndrome measured using serial MRI. Neurogastroenterol Motil (2013) 0.97
Rapid and selective high-performance liquid chromatographic method for the determination of metronidazole and its active metabolite in human plasma, saliva and gastric juice. J Chromatogr B Biomed Appl (1996) 0.97
Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats. Gut (2002) 0.97
Spontaneous dissecting intramural haematoma of the oesophagus: a rare cause of haematemesis and dysphagia. Endoscopy (1981) 0.95
Review article: The pathogenesis and management of acute colonic diverticulitis. Aliment Pharmacol Ther (2014) 0.94
Assessment of antral grinding of a model solid meal with echo-planar imaging. Am J Physiol Gastrointest Liver Physiol (2001) 0.93
Scintigraphic measurements of canine ileocolonic transit. Direct and indirect effects of eating. Gastroenterology (1986) 0.93
Effect of bran particle size on gastric emptying and small bowel transit in humans: a scintigraphic study. Gut (1995) 0.92
Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans. Aliment Pharmacol Ther (2003) 0.91
Origin of symptoms in diverticular disease. Br J Surg (2003) 0.91
The effects of loperamide, or loperamide plus simethicone, on the distribution of gut water as assessed by MRI in a mannitol model of secretory diarrhoea. Aliment Pharmacol Ther (2012) 0.90
Novel MRI tests of orocecal transit time and whole gut transit time: studies in normal subjects. Neurogastroenterol Motil (2013) 0.90
In vitro assessment of gastric mucosal transfer of anti-Helicobacter therapeutic agents. Antimicrob Agents Chemother (1997) 0.89
Effect of bran, ispaghula, and inert plastic particles on gastric emptying and small bowel transit in humans: the role of physical factors. Gut (1997) 0.87
Effects of various food ingredients on gall bladder emptying. Eur J Clin Nutr (2013) 0.87
Limited exposure of the healthy distal colon to orally-dosed formulation is further exaggerated in active left-sided ulcerative colitis. Aliment Pharmacol Ther (2000) 0.87
Psychological and colonic factors in painful diverticulosis. Br J Surg (2008) 0.87
Effect of ileal infusion of glycochenodeoxycholic acid on segmental transit, motility, and flow in the human jejunum and ileum. Gut (1989) 0.87
Effect of cholecystectomy on mouth-to-cecum transit of a liquid meal. Dig Dis Sci (1988) 0.86
Clarification of the link between polyunsaturated fatty acids and Helicobacter pylori-associated duodenal ulcer disease: a dietary intervention study. Br J Nutr (1997) 0.86
Where do all the tablets go in 1986? Gut (1986) 0.86
Fat delays emptying but increases forward and backward antral flow as assessed by flow-sensitive magnetic resonance imaging. Neurogastroenterol Motil (1999) 0.85
Impact of polyunsaturated fatty acids on human colonic bacterial metabolism: an in vitro and in vivo study. Br J Nutr (1995) 0.85
Moderation of lactulose-induced diarrhea by psyllium: effects on motility and fermentation. Am J Clin Nutr (1998) 0.85
Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations. Int J Pharm (1999) 0.85
Delayed gastric emptying and reduced postprandial small bowel water content of equicaloric whole meal bread versus rice meals in healthy subjects: novel MRI insights. Eur J Clin Nutr (2013) 0.85
Oesophageal transit, disintegration and gastric emptying of a film-coated risedronate placebo tablet in gastro-oesophageal reflux disease and normal control subjects. Aliment Pharmacol Ther (2001) 0.84
Influence of protein composition and hydrolysis method on intestinal absorption of protein in man. Gut (1985) 0.84
Loxiglumide, a CCK-A antagonist, in irritable bowel syndrome. A pilot multicenter clinical study. Ann N Y Acad Sci (1994) 0.84
Megaduodenum due to hollow visceral myopathy successfully managed by duodenoplasty and feeding jejunostomy. Gut (1991) 0.84
Stimulation of colonic motility by oral PEG electrolyte bowel preparation assessed by MRI: comparison of split vs single dose. Neurogastroenterol Motil (2014) 0.84
Effects of a 5-HT(3) antagonist, ondansetron, on fasting and postprandial small bowel water content assessed by magnetic resonance imaging. Aliment Pharmacol Ther (2010) 0.84
Use of echo planar imaging to demonstrate the effect of posture on the intragastric distribution and emptying of an oil/water meal. Neurogastroenterol Motil (1997) 0.83
Effect of experimental stress on the small bowel and colon in healthy humans. Neurogastroenterol Motil (2015) 0.83
Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine. Gut (1995) 0.83
Ethanol-induced tumour necrosis for palliation of malignant dysphagia. Lancet (1987) 0.83
ABC of the upper gastrointestinal tract: Anorexia, nausea, vomiting, and pain. BMJ (2001) 0.83
Heterotopic gastric tissue in the duodenum: a report of eight cases. Dig Dis Sci (1982) 0.83
Scintigraphic assessment of the intragastric distribution and gastric emptying of an encapsulated drug: the effect of feeding and of a proton pump inhibitor. Aliment Pharmacol Ther (1994) 0.82
Spontaneous rupture of spleen following streptokinase therapy. Lancet (1989) 0.82
Impaired oesophageal transit of capsule versus tablet formulations in the elderly. Gut (1994) 0.81
Stool water content and colonic drug absorption: contrasting effects of lactulose and codeine. Pharm Res (1999) 0.81
Prolonged elevation of galanin and tachykinin expression in mucosal and myenteric enteric nerves in trinitrobenzene sulphonic acid colitis. Neurogastroenterol Motil (2008) 0.81
Scintigraphic demonstration of lactulose-induced accelerated proximal colon transit. Gastroenterology (1992) 0.81
Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system. Pharm Res (1999) 0.80
Night-time quiescence and morning activation in the human colon: effect on transit of dispersed and large single unit formulations. Eur J Gastroenterol Hepatol (1999) 0.80
The effect of protein binding and lipophilicity of penicillins on their in-vitro flux across gastric mucosa. J Antimicrob Chemother (1998) 0.80
Echoplanar imaging in GI clinical practice: assessment of gastric emptying and antral motility in four patients. J Magn Reson Imaging (2000) 0.80
Quantitative, noninvasive assessment of antidiarrheal actions of codeine using an experimental model of diarrhea in man. Dig Dis Sci (1993) 0.79
fMRI and MEG analysis of visceral pain in healthy volunteers. Neurogastroenterol Motil (2011) 0.79
Effect of a test meal on the intragastric distribution of urea in the 13C-urea breath test for Helicobacter pylori. Gut (1995) 0.79
Measurement of gastric meal and secretion volumes using magnetic resonance imaging. Phys Med Biol (2015) 0.78
The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice. Br J Clin Pharmacol (1997) 0.78
Characterization of the time course of the superior mesenteric, abdominal aorta, internal carotid and vertebral arteries blood flow response to the oral glucose challenge test using magnetic resonance imaging. Physiol Meas (2009) 0.78
Enhanced eradication of Helicobacter pylori by pre- versus post-prandial amoxycillin suspension with omeprazole: implications for antibiotic delivery. Aliment Pharmacol Ther (1996) 0.78
Small bowel transit of a bran meal residue in humans: sieving of solids from liquids and response to feeding. Gut (1998) 0.78
Proximal colonic response and gastrointestinal transit after high and low fat meals. Dig Dis Sci (1993) 0.77
Delayed postprandial plasma bile acid response in coeliac patients with slow mouth-caecum transit. Clin Sci (Lond) (1987) 0.77
Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori. Assessment of the importance of antibiotic dose timing in relation to meals. Aliment Pharmacol Ther (1994) 0.77
Helicobacter pylori eradication in clinical practice: one-week low-dose triple therapy is preferable to classical bismuth based triple therapy. Aliment Pharmacol Ther (1996) 0.77
Impact of dietary fiber on absorption from the small intestine. Curr Opin Gastroenterol (1999) 0.77
The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water. Int J Pharm (2001) 0.76
Peritoneal seeding of pancreatic cancer following transperitoneal biliary procedures. Br J Surg (1995) 0.76
Progress report. Gut (2004) 0.75
Surgery for pancreatic cancer. BMJ (1994) 0.75
Influence of antisecretory drugs on Helicobacter pylori eradication rates. Gut (2004) 0.75
How can we improve on the efficacy of Helicobacter pylori treatment? Ital J Gastroenterol Hepatol (1998) 0.75
Nutritional issues in irritable bowel syndrome. Curr Opin Clin Nutr Metab Care (2001) 0.75
Mebeverine decreases mass movements and stool frequency in lactulose-induced diarrhoea. Aliment Pharmacol Ther (1998) 0.75
Inhibition of jejunal water and electrolyte absorption by therapeutic doses of clindamycin in man. Clin Sci (Lond) (1984) 0.75